Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

MEA Anti Fungal Agents Companies

ID: MRFR/Pharma/1942-HCR
84 Pages
Satyendra Maurya
Last Updated: April 06, 2026
Pharmaceutical industry in the Middle East and Africa region includes companies involved in the research, development, manufacturing, and distribution of anti-fungal agents. These medications are used to treat various fungal infections. 
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the MEA Anti Fungal Agents Market

MEA Anti-Fungal Agents Key Companies

Latest MEA Anti-Fungal Agents Companies Update

 Pfizer collaborates with the Egyptian Ministry of Health to launch a program for early diagnosis and treatment of fungal infections in high-risk groups.

Roche enters into a partnership with a Moroccan pharmaceutical company to distribute its antifungal drug, Posaconazole, in the region.

Glenmark Pharmaceuticals launches Itraconazole capsules in Kenya, expanding access to a first-line antifungal medication for patients with blastomycosis.

Janssen Pharmaceuticals launches Isavuconazole in South Africa, offering a broad-spectrum antifungal agent for the treatment of various fungal infections

List of MEA Anti-Fungal Agents Key Companies in the Market

  • Novartis AG
  • Pfizer Inc.
  • Sanofi-Aventis
  • Merck & Co. Inc.
  • Enzon Pharmaceuticals Inc.
  • Bayer AG
  • Astellas Pharma Inc.
  • GlaxoSmithKline plc
  • Abbott
  • Sigma-Aldrich